Abacavir and Lamivudine 300 mg/1 (Abacavir and Lamivudine TABLET, FILM COATED) 300 mg/1

Abacavir and Lamivudine 300 mg/1 tablets are a combination medication used in the treatment of HIV infection. This oral medication is designed to help manage the virus and support overall health.

Strength

300 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (33342-440-07)

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Abacavir and Lamivudine 300 mg/1 tablets are primarily used in the management of HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to improve immune function and reduce the risk of HIV-related complications. It is often prescribed as part of a broader treatment plan that includes other medications and lifestyle adjustments.

Side Effects

Common effects of Abacavir and Lamivudine 300 mg/1 tablets may include headaches, nausea, and fatigue. Some individuals might experience skin rashes or changes in appetite. These effects vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Abacavir and Lamivudine 300 mg/1 tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring and follow-up appointments are recommended to ensure the medication is working effectively and to manage any potential side effects.

Avoid Interactions

Abacavir and Lamivudine 300 mg/1 tablets may interact with other medications, including certain antiviral drugs and immune system suppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Abacavir and Lamivudine 300 mg/1 tablets are used in the management of HIV infection. They help reduce the amount of HIV in the body and support immune function.

Abacavir and Lamivudine 300 mg/1 tablets are taken orally, typically as prescribed by a healthcare professional. Follow the dosage and administration instructions provided.

Common side effects may include headaches, nausea, fatigue, and skin rashes. These effects vary and are not experienced by everyone.

Abacavir and Lamivudine may interact with other medications, so it is important to discuss all current medications with a healthcare professional.

Alcohol consumption should be discussed with a healthcare professional to ensure it is safe while taking Abacavir and Lamivudine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.